Labeled Abiraterone. A steroidal cytochrome P 450 17alpha-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. Form: White to Off-White Solid Melting Point: 213-215C Solubility: Methanol
Molecular Weight:
353.53
Form:
White to Off-White Solid
* VAT and and shipping costs not included. Errors and price changes excepted
